Organisation paid for research Program year 2022 Source: CMS Open Payments

Bruce A Segal MD

Neither a doctor nor a teaching hospital

Research payments

$106,184

59 payments

Through program year 2022, Bruce A Segal MD is reported as receiving $106,184 in research payments, across 59 payments.

By program year

4 rows
Year Kind Amount Payments
2022 Research $73,795 12
2021 Research $23,055 3
2020 Research $5,985 33
2019 Research $3,349 11

Breakdown

Who paid Research payments · program years 2019–2022
  1. AbbVie, Inc. $73,795 12 payments
  2. Allergan Inc. $32,389 47 payments
Studies the money was for Research payments · program years 2019–2022
  1. Comparison of Bimatoprost SR to Selective Laser Trabeculoplasty in Patients With Open-Angle Glaucoma or Ocular Hypertension $62,846 9 payments
  2. An Extension Trial to Evaluate the Long-term Safety and Efficacy of Bimatoprost SR in Patients with Open Angle Glaucoma or Ocular Hypertension $20,841 2 payments
  3. Study of AGN-190584 Eye Drops to Assess Safety and Efficacy in Participants Aged 40-80 Years With Pseudophakic Presbyopia $8,000 2 payments
  4. A Comparison of Bimatoprost SR to Selective Laser Trabeculoplasty in Patients with Open-Angle Glaucoma or Ocular Hypertension $3,943 18 payments
  5. Long-term Safety and Efficacy Extension Trial of Bimatoprost SR $2,949 1 payment
  6. A multicenter, open-label, single arm study in patients with open angle glaucoma or ocular hypertension who have not had previous laser trabeculoplasty treatment $2,215 1 payment
  7. An Extension Trial to Evaluate the Long-term Safety and Efficacy of Bimatoprost SR in Patients with Open Angle Glaucoma or Ocular Hypertension $1,759 14 payments
  8. An Extension Trial to Evaluate the Long-term Safety and Efficacy of Bimatoprost SR in Patient with Open Angle Glaucoma or Ocular Hypertension $1,512 7 payments
  9. Efficacy and Safety of Bimatoprost Sustained-Release (Sr) in Patients With Open-Angle Glaucoma Or Ocular Hypertension $1,425 4 payments
  10. Efficacy and Safety of Bimatoprost Sustained-Release Sr in Patients With Open-Angle Glaucoma Or Ocular Hypertension $695 1 payment

What you are looking at

A noncovered recipient is an organisation paid for research that is neither an individual clinician nor a teaching hospital — typically a contract research organisation, a foundation or a trial site network. They receive 81% of all reported research money, which is why they appear here at all.

Provenance

Source: CMS Open Payments · through program year 2022

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record